The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ensituximab (E) in patients (pts) with refractory metastatic colorectal cancer (mCRC): Results of a phase I/II clinical trial.
 
Richard D. Kim
No Relationships to Disclose
 
Philip M. Arlen
Employment - Precision Biologics
Leadership - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
Patents, Royalties, Other Intellectual Property - Precision Biologics
Travel, Accommodations, Expenses - Precision Biologics
 
Kwong Y. Tsang
Employment - Precision Biologics
Leadership - Precision Biologics
Patents, Royalties, Other Intellectual Property - Precision Biologics
Travel, Accommodations, Expenses - Precision Biologics
 
Sharon Mavroukakis
Employment - Precision Biologics
Leadership - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
Travel, Accommodations, Expenses - Precision Biologics
 
Anjum Zaki
Employment - Precision Biologics
 
Karen Cui
Employment - Precision Biologics
Travel, Accommodations, Expenses - Precision Biologics
 
Nilofer Saba Azad
Honoraria - Bayer/Onyx
Consulting or Advisory Role - Dava Oncology
Research Funding - Agios (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Genentech (Inst); Kinex (Inst); Precision Biologics (Inst)
 
Benjamin R. Tan
Consulting or Advisory Role - Roche/Genentech
Research Funding - Bayer; Boehringer Ingelheim; Eisai; Exelixis; Lilly; Merck Serono; Pfizer; Roche/Genentech; Sillajen; tyrogenex
 
Elizabeth Poplin
Research Funding - Neogenix Oncology (Inst)
Travel, Accommodations, Expenses - Clovis Oncology
 
Michael Morse
Stock and Other Ownership Interests - PhytoChem
Honoraria - Astellas Pharma; Bayer; Boehringer Ingelheim; EMD Serono; Etubics; Genentech/Roche; Ipsen; Lexicon; Merrimack; Novartis; Onyx; Regeneron; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Genentech/Roche; Novartis; Taiho Pharmaceutical
Research Funding - Advanced Accelerator Applications (Inst); AlphaVax (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lexicon (Inst); MedImmune (Inst); Merck (Inst); Onyx (Inst); Precision Biologics (Inst)
 
Muhammad Shaalan Beg
No Relationships to Disclose